GTG Labs - GENE Enterprise Value-to-Revenue Multiple

Public company logo of Genetic Technologies (GENE)

Genetic Technologies leads in preventive diagnostics, creating unique GeneType tests for the early detection of diabetes and cancer. The EV/Sales history confirms the market valuation of assets, where the indicator determines the status of the value-to-revenue parameter. Revenue growth is driven by personalized medicine and expansion in Europe, while streamlined courier logistics ensure the prompt delivery of biomaterials.

GENE (Genetic Technologies Ltd) EV/Sales Multiple history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Genetic Technologies Limited (GENE)

- share price and consensus valuation forecast:
Fundamental valuation:Genetic Technologies Ltd (GENE)
Manufactured product of gtglabs.com

Genetic Technologies' high concentration of scientific personnel and unique R&D potential create a foundation for growth in operating revenues from precision diagnostics. The ratio of Enterprise Value to revenue, reflected on this EV/Sales multiplier chart, allows for an assessment of the market value of assets excluding debt, where a sharp vertical spike in the line warns the investor of an overbought asset and the risk of a speculative bubble.

Competitor analysis for Genetic Technologies

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple CDIO (Cardio Diagnostics)|ONCO - Company Value to Revenue|VRAX: Company Value to Revenue|bluejaydx.com (BJDX) - Company Value to Revenue|AWH: EV/Sales Multiple|AXDX: Enterprise Value-to-Revenue Coefficient|CNTG (CENTOGENE N.V.) - EV/Sales Multiple|Company Value to Revenue Enzo Biochem, Inc. (ENZ)|FRES - Enterprise Value to Sales Volume|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue